Epstein Files Search

EFTA01538740Set 10

2010-06-3096p9,531w

ANALYTICS INC CLASS A 92345Y-10-6 VRSK P P US Mid Cap/Small Cap AMYRIS INC 03236M-10-1 AMRS APOLLO COMMERCIAL REAL ESTATE FINANCE INC 03762U ... 10/4 10/5 10/5 Type Pending Sales, Maturities, Redemptions Sale Sale Sale Sale Sale Description AMYRIS INC VERISK ANALYTICS INC CLASS A APOLLO COMMERCIAL REAL ESTATE ELSTER GROUP SE FINANCE ... Description Pending Securities Purchased 9/27 Purchase Purchase Purchase Purchase Purchase Total Pending Securities Purchased AMYRIS INC VERISK ANALYTICS INC CLASS A ENTROPIC COMMUNICATIONS INC ELSTER GROUP SE CITIGROUP CAPITAL XIII

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01538740.pdf

EFTA00025526Set 8

2020-09-116p2,926w

article » McDermott Will McKool Smith INTELLECTUAL PROPERTY Miller Korzenik Morgan Lewis Cannabinoid Maker Hits Amyris With $881M Trade Secrets Suit Morrison Mahoney A cannabinoid manufacturer slapped biotech company Amyris with ... American International Group Inc. the firm sold it. Ameriprise Financial Inc. Read full article » Amyris Inc. Apple Inc. BANKING BNP Paribas SA Bank GCs Don't Have

https://www.justice.gov/epstein/files/DataSet%208/EFTA00025526.pdf

EFTA01538836Set 10

2010-10-0197p9,433w

prior statement period and settled in current statement period Type Settled Sales/Maturities/Redemptions Sale Description AMYRIS INC @ 17.0484 BROKERAGE TAX &/OR SEC Quantity (2,500.000) 42,621.00 125.00 .73 J.P. MORGAN ... Settled Sales/Maturities/Redemptions Trade Date Settlement Date 10/1 Type Settled Securities Purchased 9/27 Purchase Description AMYRIS INC @ 16.00 J.P. MORGAN SECURITIES LLC TRADE DATE 09/27/10 9/27 10/1 Purchase VERISK ANALYTICS

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01538836.pdf

EFTA00284062Set 9

12p1,933w

Director of tech. Advisory positions at and metabolomics leader at the Chemoprotection Bolt Threads, Amyris, the DOE's Joint Genome Center at Hopkins Miraculex Institute University Lawrencee nV Bolt SYNTHETIC ... GENOMICS National 0 MERCK tJPON) JOHNS HOPKINS AMYRIS. Threads Laboratory SCHOOL of MEDICINE 11 brightseed EFTA00284072 Supported by world-class investors Y CGC Horizons entures 50 fit ;*#',11:1 GERMIN8

https://www.justice.gov/epstein/files/DataSet%209/EFTA00284062.pdf

EFTA01917808Set 10

2014-07-134p916w

news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01917808.pdf

EFTA00610320Set 9

1p379w

derivative markets - First analyst in group history to first-author a distributed research article Amyris Biotechnologies Emeryville, California Scientific Computing Intern May 2011 - Aug 2011 - Built a specification language

https://www.justice.gov/epstein/files/DataSet%209/EFTA00610320.pdf

EFTA00631419Set 9

2014-07-102p661w

news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids

https://www.justice.gov/epstein/files/DataSet%209/EFTA00631419.pdf

EFTA00993299Set 9

2014-07-134p1,029w

news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids

https://www.justice.gov/epstein/files/DataSet%209/EFTA00993299.pdf

EFTA01917108Set 10

2014-07-133p899w

news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01917108.pdf

EFTA00805732Set 9

39p13,737w

corn farmers. But most ethanol is still made is would-be microbial fuel-maker Amyris. The industry from the edible kernels of corn plants, instead of the for "advanced biofuels

https://www.justice.gov/epstein/files/DataSet%209/EFTA00805732.pdf

EFTA01491641Set 10

2010-09-011p146w

CLASS A 92345Y-10-6 VRSK US Mid Cap/Small Cap P AMYRIS INC 17.25 N/A 03238M-10-1 AMRS P APOLLO COMMERCIAL REAL ESTATE 16.07 N/A 996% FINANCE

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01491641.pdf

EFTA01919154Set 10

2014-07-133p767w

news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01919154.pdf

EFTA01916477Set 10

2014-07-133p795w

news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01916477.pdf

EFTA01491801Set 10

2011-04-231p144w

Date Type Description Quantity Amount Proceeds Tax Cost Gain/Loss Settled Sales/Maturities/Redemptions 9/28 1011 Sale AMYRIS INC (2500.000) 16.996 42,496.27 (40,000.00) 2,495.27 S. Q 17.0484 42,621.00 BROKERAGE

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01491801.pdf

EFTA01918194Set 10

2014-07-134p1,035w

news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01918194.pdf

EFTA01980272Set 10

2014-08-113p714w

news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01980272.pdf

EFTA01979712Set 10

2014-07-134p1,027w

news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01979712.pdf

EFTA01491804Set 10

2010-10-011p162w

Date Date Type Description Quantity Amount Market Cost Settled Securities Purchased 9/27 10/1 Purchase AMYRIS INC 2,500.000 16.00 (40.000 00) 18.00 J.P. MORGAN SECURITIES LLC TRADE DATE 09/27/10 9/27

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01491804.pdf

EFTA01920172Set 10

2014-07-113p663w

news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01920172.pdf

EFTA00995805Set 9

2014-08-254p1,076w

news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids

https://www.justice.gov/epstein/files/DataSet%209/EFTA00995805.pdf